NEVVI Medicare utilization intelligence

← back

Provider profile

MELOGRANA, FRANK M.D.

Urology · NPI 1528050895 · ORMOND BEACH, FL

2
Groups
33
Codes · 2024
37,930
Disclosed services

MELOGRANA, FRANK is a Urology in ORMOND BEACH, FL, a member of 2 medical groups, who billed 33 distinct codes to Medicare Part B in 2024.

Groups: FLORIDA UROLOGY CENTER PA (ORMOND BEACH, FL) · HALIFAX HEALTHCARE SYSTEMS INC (DAYTONA BCH, FL) — member of 2 groups; the volumes below are this clinician's personal volume and are not attributed to any single group

Year: 2024 · 2023 · 2022 🔒 · 2021 🔒 · 2020 🔒

Provider overview · all codes · CY2024

37,930
disclosed services
33
codes billed to Medicare Part B
Prior year · CY2023 22,339 disclosed services

This provider's disclosed Medicare payments across all codes were premium in CY2024.

Dollars, place-of-service mix, business mix and national standing are part of the market analytics platform — built, not launched yet. Notify me at launch →

All figures are disclosed (CMS suppresses fewer-than-11-beneficiary rows) Medicare Part B fee-for-service — a subset, never complete totals; volumes are personal to this NPI, not attributed to any group. Standing is a billed-volume position among specialty peers with disclosed billing (national percentile; a provider's true standing can only be higher, never lower), not a statement about care. See Methods & Sources.

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
This provider's Medicare volumes — services, beneficiary-episodes, and charges — are part of the market analytics platform — built, not launched yet. Notify me at launch →
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1071 Injection, testosterone cypionate, 1 mg premiumpremium premiumpremium
82570 Creatinine level to test for kidney function or muscle injury premiumpremium premiumpremium
87798 Detection test by nucleic acid for organism, amplified probe technique premiumpremium premiumpremium
81003 Automated urinalysis test premiumpremium premiumpremium
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's premiumpremium premiumpremium
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more premiumpremium premiumpremium
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more premiumpremium premiumpremium
81001 Manual urinalysis test with examination using microscope, automated premiumpremium premiumpremium
51798 Ultrasound measurement of bladder capacity after voiding premiumpremium premiumpremium
96372 Injection of drug or substance under skin or into muscle premiumpremium premiumpremium
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more premiumpremium premiumpremium
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month premiumpremium premiumpremium
52000 Diagnostic exam of bladder and urethra using an endoscope premiumpremium premiumpremium
87481 Detection test for candida species (yeast), amplified probe technique premiumpremium premiumpremium
87801 Detection test by nucleic acid for multiple organisms, amplified probe(s) technique premiumpremium premiumpremium
87500 Detection test by nucleic acid for vancomycin resistance strep (vre), amplified probe technique premiumpremium premiumpremium
87640 Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique premiumpremium premiumpremium
87653 Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique premiumpremium premiumpremium
J1580 Injection, garamycin, gentamicin, up to 80 mg premiumpremium premiumpremium
74018 X-ray of abdomen, 1 view premiumpremium premiumpremium
51741 Electronic assessment of bladder emptying premiumpremium premiumpremium
74176 Ct scan of abdomen and pelvis without contrast premiumpremium premiumpremium
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more premiumpremium premiumpremium
50590 Shock wave crushing of kidney stones premiumpremium premiumpremium
52281 Dilation of urethra using an endoscope premiumpremium premiumpremium
99427 Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month premiumpremium premiumpremium
55706 Needle biopsy of prostate gland using image guidance premiumpremium premiumpremium
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes premiumpremium premiumpremium
53660 Initial dilation of urethra in female premiumpremium premiumpremium
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more premiumpremium premiumpremium
74420 Imaging of urinary tract following injection of a contrast agent premiumpremium premiumpremium
76872 Ultrasound scan of pelvic region through rectum premiumpremium premiumpremium
52353 Crushing of stone of ureter using an endoscope premiumpremium premiumpremium

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.